Immunogenicity of High-Dose MVA-Based MERS Vaccine Candidate in Mice and Camels

Abstract

MVA-MERS vaccine, administered in a homologous prime-boost regimen, induced high levels of neutralising anti-MERS-CoV antibodies in mice and camels. This could be considered for further development and evaluation as a dromedary vaccine to reduce MERS-CoV transmission to humans.